Altre lingue Medlive Technology Co., Ltd.

Azioni

2192

KYG5961B1041

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:20 26/04/2024			Variaz. 5gg	Var. 1 gen.
8,15 ^HKD	-1,45%		+11,34%	-3,89%

25/03	Medlive Technology Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
28/02	Medlive Technology raddoppierà l'utile nel 2023	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024	25/03
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Medlive Technology to Double Profit in 2023	28/02
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023	28/02
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan	13/10/23
Medlive Technology’s Profit Soars 266% in H1	30/08/23
Medlive Technology Co., Ltd. Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 December 2023	29/08/23
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Medlive Technology to More than Triple H1 Profit	03/08/23
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023	03/08/23
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon	13/06/23
Medlive Technology Co., Ltd. Announces Executive Changes	12/06/23
Medlive Technology Co., Ltd. Announces Director Changes	14/04/23
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2022, Payable on July 10, 2023	23/03/23
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Medlive Technology's Profit to Rise in 2022	02/03/23
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	02/03/23
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs	06/02/23
Medlive Technology Sees No Explanation For Unusual Share Price Movement	13/12/22
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect	03/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Medlive Technology Co., Ltd.

Azioni

2192

KYG5961B1041

Altre lingue

Filtri